MYNZ

Neutral

David Lazar secures control of Mainz Biomed (Nasdaq: MYNZ) with $6M deal

David E. Lazar has secured control of Mainz Biomed (Nasdaq: MYNZ) by acquiring 5,000,000 Preferred Shares for $6,000,000. These shares are convertible...

Stock Titan 2 mins ago 0

Neutral

Quantum Cyber N.V. (QUCY) director discloses 2,000 Ordinary Shares on Form 3

Quantum Cyber N.V. director Ben-Tzvi Avraham has filed an initial Form 3, reporting beneficial ownership of 2,000 Ordinary Shares directly in the comp...

Stock Titan 54 mins ago 0